Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Background “Vision 2020 – the right to sight” is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of concrete action plans at the national and district levels. Accordingly, baseline data are needed for the planning, monitoring, follow-up and eva...
Saved in:
Published in | Journal of diabetes and metabolic disorders Vol. 14; no. 1; p. 21 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
08.04.2015
BioMed Central Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
“Vision 2020 – the right to sight” is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of concrete action plans at the national and district levels. Accordingly, baseline data are needed for the planning, monitoring, follow-up and evaluation of this program. The present study aimed to better characterize visual impairment and blindness in Cameroonian diabetics by providing with baseline data on the prevalence and main causes of these affections.
Methods
This was a hospital-based cross-sectional study, conducted from October 2004 to October 2006 at the Department of Ophthalmology of the Douala General Hospital, Cameroon. We included 407 diabetic patients who were referred from diabetes clinics for ophthalmologic evaluation. Ophthalmologic data included visual acuity, intra-ocular pressure, fundoscopy and fluorescein angiography.
Results
The prevalence of blindness and poor vision were respectively 12.3% and 17.4% with regard to the worst eyes. Fifty nine (14.5%) patients were found with diabetic maculopathy, of whom 25.4% (15/59) had poor vision, and 25.4% (15/59) were blind. The prevalence of sight threatening retinopathy (severe non-proliferative and proliferative) was 17.4%. The degree of visual impairment was comparable in both diabetic types (p = 0.825), and it increased with the severity of retinopathy (p < 0.0001), as well as that of maculopathy (p <0.0001). The prevalence of glaucoma was 15% (61/407) when considering the worst eyes. The severity of visual impairment increased with the severity of glaucoma (p = 0.001). One hundred and twenty-one (29.7%) patients presented with cataract irrespective of its location or severity. Cataract was significantly associated with poor vision and blindness (p < 0.0001). Hypertensive retinopathy (4.9%), papillary ischaemia (2.7%), vaso-occlusive eye disease (2.5%), and age-related macular edema (2%) were the other potential causes of visual impairment and blindness encountered the most in our setting. Age ≥ 50 years, male sex, duration of diabetes and hypertension variously increased the risk of having glaucoma, cataract, diabetic retinopathy or maculopathy.
Conclusion
Poor vision and blindness are frequent in Cameroonian diabetics, and their causes are similar to those reported by various other surveys: mainly cataract, glaucoma, diabetic retinopathy and maculopathy. |
---|---|
AbstractList | Background "Vision 2020 - the right to sight" is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of concrete action plans at the national and district levels. Accordingly, baseline data are needed for the planning, monitoring, follow-up and evaluation of this program. The present study aimed to better characterize visual impairment and blindness in Cameroonian diabetics by providing with baseline data on the prevalence and main causes of these affections. Methods This was a hospital-based cross-sectional study, conducted from October 2004 to October 2006 at the Department of Ophthalmology of the Douala General Hospital, Cameroon. We included 407 diabetic patients who were referred from diabetes clinics for ophthalmologic evaluation. Ophthalmologic data included visual acuity, intra-ocular pressure, fundoscopy and fluorescein angiography. Results The prevalence of blindness and poor vision were respectively 12.3% and 17.4% with regard to the worst eyes. Fifty nine (14.5%) patients were found with diabetic maculopathy, of whom 25.4% (15/59) had poor vision, and 25.4% (15/59) were blind. The prevalence of sight threatening retinopathy (severe non-proliferative and proliferative) was 17.4%. The degree of visual impairment was comparable in both diabetic types (p = 0.825), and it increased with the severity of retinopathy (p < 0.0001), as well as that of maculopathy (p <0.0001). The prevalence of glaucoma was 15% (61/407) when considering the worst eyes. The severity of visual impairment increased with the severity of glaucoma (p = 0.001). One hundred and twenty-one (29.7%) patients presented with cataract irrespective of its location or severity. Cataract was significantly associated with poor vision and blindness (p < 0.0001). Hypertensive retinopathy (4.9%), papillary ischaemia (2.7%), vaso-occlusive eye disease (2.5%), and age-related macular edema (2%) were the other potential causes of visual impairment and blindness encountered the most in our setting. Age [greater than or equai to] 50 years, male sex, duration of diabetes and hypertension variously increased the risk of having glaucoma, cataract, diabetic retinopathy or maculopathy. Conclusion Poor vision and blindness are frequent in Cameroonian diabetics, and their causes are similar to those reported by various other surveys: mainly cataract, glaucoma, diabetic retinopathy and maculopathy. Keywords: Visual impairment, Diabetes, Diabetic retinopathy, Diabetic maculopathy, Cataract, Glaucoma, Cameroon, Sub-Saharan Africa "Vision 2020 - the right to sight" is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of concrete action plans at the national and district levels. Accordingly, baseline data are needed for the planning, monitoring, follow-up and evaluation of this program. The present study aimed to better characterize visual impairment and blindness in Cameroonian diabetics by providing with baseline data on the prevalence and main causes of these affections. This was a hospital-based cross-sectional study, conducted from October 2004 to October 2006 at the Department of Ophthalmology of the Douala General Hospital, Cameroon. We included 407 diabetic patients who were referred from diabetes clinics for ophthalmologic evaluation. Ophthalmologic data included visual acuity, intra-ocular pressure, fundoscopy and fluorescein angiography. The prevalence of blindness and poor vision were respectively 12.3% and 17.4% with regard to the worst eyes. Fifty nine (14.5%) patients were found with diabetic maculopathy, of whom 25.4% (15/59) had poor vision, and 25.4% (15/59) were blind. The prevalence of sight threatening retinopathy (severe non-proliferative and proliferative) was 17.4%. The degree of visual impairment was comparable in both diabetic types (p = 0.825), and it increased with the severity of retinopathy (p < 0.0001), as well as that of maculopathy (p <0.0001). The prevalence of glaucoma was 15% (61/407) when considering the worst eyes. The severity of visual impairment increased with the severity of glaucoma (p = 0.001). One hundred and twenty-one (29.7%) patients presented with cataract irrespective of its location or severity. Cataract was significantly associated with poor vision and blindness (p < 0.0001). Hypertensive retinopathy (4.9%), papillary ischaemia (2.7%), vaso-occlusive eye disease (2.5%), and age-related macular edema (2%) were the other potential causes of visual impairment and blindness encountered the most in our setting. Age ≥ 50 years, male sex, duration of diabetes and hypertension variously increased the risk of having glaucoma, cataract, diabetic retinopathy or maculopathy. Poor vision and blindness are frequent in Cameroonian diabetics, and their causes are similar to those reported by various other surveys: mainly cataract, glaucoma, diabetic retinopathy and maculopathy. BACKGROUND"Vision 2020 - the right to sight" is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of concrete action plans at the national and district levels. Accordingly, baseline data are needed for the planning, monitoring, follow-up and evaluation of this program. The present study aimed to better characterize visual impairment and blindness in Cameroonian diabetics by providing with baseline data on the prevalence and main causes of these affections. METHODSThis was a hospital-based cross-sectional study, conducted from October 2004 to October 2006 at the Department of Ophthalmology of the Douala General Hospital, Cameroon. We included 407 diabetic patients who were referred from diabetes clinics for ophthalmologic evaluation. Ophthalmologic data included visual acuity, intra-ocular pressure, fundoscopy and fluorescein angiography. RESULTSThe prevalence of blindness and poor vision were respectively 12.3% and 17.4% with regard to the worst eyes. Fifty nine (14.5%) patients were found with diabetic maculopathy, of whom 25.4% (15/59) had poor vision, and 25.4% (15/59) were blind. The prevalence of sight threatening retinopathy (severe non-proliferative and proliferative) was 17.4%. The degree of visual impairment was comparable in both diabetic types (p = 0.825), and it increased with the severity of retinopathy (p < 0.0001), as well as that of maculopathy (p <0.0001). The prevalence of glaucoma was 15% (61/407) when considering the worst eyes. The severity of visual impairment increased with the severity of glaucoma (p = 0.001). One hundred and twenty-one (29.7%) patients presented with cataract irrespective of its location or severity. Cataract was significantly associated with poor vision and blindness (p < 0.0001). Hypertensive retinopathy (4.9%), papillary ischaemia (2.7%), vaso-occlusive eye disease (2.5%), and age-related macular edema (2%) were the other potential causes of visual impairment and blindness encountered the most in our setting. Age ≥ 50 years, male sex, duration of diabetes and hypertension variously increased the risk of having glaucoma, cataract, diabetic retinopathy or maculopathy. CONCLUSIONPoor vision and blindness are frequent in Cameroonian diabetics, and their causes are similar to those reported by various other surveys: mainly cataract, glaucoma, diabetic retinopathy and maculopathy. Background “Vision 2020 – the right to sight” is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of concrete action plans at the national and district levels. Accordingly, baseline data are needed for the planning, monitoring, follow-up and evaluation of this program. The present study aimed to better characterize visual impairment and blindness in Cameroonian diabetics by providing with baseline data on the prevalence and main causes of these affections. Methods This was a hospital-based cross-sectional study, conducted from October 2004 to October 2006 at the Department of Ophthalmology of the Douala General Hospital, Cameroon. We included 407 diabetic patients who were referred from diabetes clinics for ophthalmologic evaluation. Ophthalmologic data included visual acuity, intra-ocular pressure, fundoscopy and fluorescein angiography. Results The prevalence of blindness and poor vision were respectively 12.3% and 17.4% with regard to the worst eyes. Fifty nine (14.5%) patients were found with diabetic maculopathy, of whom 25.4% (15/59) had poor vision, and 25.4% (15/59) were blind. The prevalence of sight threatening retinopathy (severe non-proliferative and proliferative) was 17.4%. The degree of visual impairment was comparable in both diabetic types (p = 0.825), and it increased with the severity of retinopathy (p < 0.0001), as well as that of maculopathy (p <0.0001). The prevalence of glaucoma was 15% (61/407) when considering the worst eyes. The severity of visual impairment increased with the severity of glaucoma (p = 0.001). One hundred and twenty-one (29.7%) patients presented with cataract irrespective of its location or severity. Cataract was significantly associated with poor vision and blindness (p < 0.0001). Hypertensive retinopathy (4.9%), papillary ischaemia (2.7%), vaso-occlusive eye disease (2.5%), and age-related macular edema (2%) were the other potential causes of visual impairment and blindness encountered the most in our setting. Age ≥ 50 years, male sex, duration of diabetes and hypertension variously increased the risk of having glaucoma, cataract, diabetic retinopathy or maculopathy. Conclusion Poor vision and blindness are frequent in Cameroonian diabetics, and their causes are similar to those reported by various other surveys: mainly cataract, glaucoma, diabetic retinopathy and maculopathy. "Vision 2020 - the right to sight" is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of concrete action plans at the national and district levels. Accordingly, baseline data are needed for the planning, monitoring, follow-up and evaluation of this program. The present study aimed to better characterize visual impairment and blindness in Cameroonian diabetics by providing with baseline data on the prevalence and main causes of these affections. This was a hospital-based cross-sectional study, conducted from October 2004 to October 2006 at the Department of Ophthalmology of the Douala General Hospital, Cameroon. We included 407 diabetic patients who were referred from diabetes clinics for ophthalmologic evaluation. Ophthalmologic data included visual acuity, intra-ocular pressure, fundoscopy and fluorescein angiography. The prevalence of blindness and poor vision were respectively 12.3% and 17.4% with regard to the worst eyes. Fifty nine (14.5%) patients were found with diabetic maculopathy, of whom 25.4% (15/59) had poor vision, and 25.4% (15/59) were blind. The prevalence of sight threatening retinopathy (severe non-proliferative and proliferative) was 17.4%. The degree of visual impairment was comparable in both diabetic types (p = 0.825), and it increased with the severity of retinopathy (p < 0.0001), as well as that of maculopathy (p <0.0001). The prevalence of glaucoma was 15% (61/407) when considering the worst eyes. The severity of visual impairment increased with the severity of glaucoma (p = 0.001). One hundred and twenty-one (29.7%) patients presented with cataract irrespective of its location or severity. Cataract was significantly associated with poor vision and blindness (p < 0.0001). Hypertensive retinopathy (4.9%), papillary ischaemia (2.7%), vaso-occlusive eye disease (2.5%), and age-related macular edema (2%) were the other potential causes of visual impairment and blindness encountered the most in our setting. Age [greater than or equai to] 50 years, male sex, duration of diabetes and hypertension variously increased the risk of having glaucoma, cataract, diabetic retinopathy or maculopathy. Poor vision and blindness are frequent in Cameroonian diabetics, and their causes are similar to those reported by various other surveys: mainly cataract, glaucoma, diabetic retinopathy and maculopathy. |
ArticleNumber | 21 |
Audience | General |
Author | Bilong, Yannick Jingi, Ahmadou M Mvogo, Côme Ebana Nansseu, Jobert Richie N Noubiap, Jean Jacques N Ellong, Augustin |
Author_xml | – sequence: 1 givenname: Ahmadou M surname: Jingi fullname: Jingi, Ahmadou M organization: Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I – sequence: 2 givenname: Jobert Richie N surname: Nansseu fullname: Nansseu, Jobert Richie N organization: Department of Public Health, Faculty of Medicine and Biomedical Sciences – sequence: 3 givenname: Jean Jacques N surname: Noubiap fullname: Noubiap, Jean Jacques N email: noubiapjj@yahoo.fr organization: Internal Medicine Unit, Edéa Regional Hospital, Medical Diagnostic Center – sequence: 4 givenname: Yannick surname: Bilong fullname: Bilong, Yannick organization: Department of Ophthalmology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I – sequence: 5 givenname: Augustin surname: Ellong fullname: Ellong, Augustin organization: Department of Ophthalmology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I – sequence: 6 givenname: Côme Ebana surname: Mvogo fullname: Mvogo, Côme Ebana organization: Department of Ophthalmology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25866740$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kk2LHCEQhiVsyH5kf0AuoSEQ9tIbddS2c1gYJp8wkEOSs6hdzrh060S7B_LvYzObzUxIlMJCn3q1yrpEZyEGQOgFwbeESPEmM0wxrjHhs5GaPUEXlBZHcEnOjvxzdJ3zPS6jaaQk4hk6p1wK0TB8gdbvvDYwQq506Kq9z5PuKz_stE8DhLHyocqTqb_qrU46VEuXvNVvK9j7DoKFyqU4VCs9QIoxPEdPne4zXD-sV-j7h_ffVp_q9ZePn1fLdW25kGMNuuXEcO7YgjKgghNnDeYdblkniHBSOuMM4ZJCa62RjWWyNRLrhhhigC6u0N1BdzeZATpbHpp0r3bJDzr9VFF7dXoS_FZt4l6xRUubRVMEbh4EUvwxQR7V4LOFvtcB4pQVEc0CN0xgUtBXf6H3cUqhpFcoOReZMPyH2ugelA8ulnvtLKqWnBEhWkJZoW7_QZXZweBt-V7ny_5JwOujgC3oftzm2E-jjyGfguQA2hRzTuAei0GwmttFHdpFlVaZjag55uVxFR8jfjdHAegByOUobCAdpf5f1V_yLslQ |
CitedBy_id | crossref_primary_10_3928_23258160_20190108_05 crossref_primary_10_1371_journal_pone_0303388 crossref_primary_10_1038_s41433_018_0055_x crossref_primary_10_3389_fphar_2020_00108 crossref_primary_10_1136_bmjopen_2022_060786 crossref_primary_10_1186_s12906_016_1251_5 crossref_primary_10_1371_journal_pone_0256145 crossref_primary_10_2196_35044 crossref_primary_10_1093_gerona_glaa304 crossref_primary_10_1016_j_jtos_2017_01_001 crossref_primary_10_1136_bmjopen_2023_077552 crossref_primary_10_1371_journal_pone_0276194 |
Cites_doi | 10.1016/S0161-6420(99)90003-9 10.1136/bjo.87.9.1069 10.1167/iovs.10-5414 10.1186/1471-2415-14-19 10.1186/1471-2458-14-696 10.2337/diacare.27.5.1047 10.1136/bjo.86.9.1014 10.1016/S0181-5512(04)96107-4 10.1038/eye.2014.131 10.1136/bjo.2004.053397 10.1056/NEJM199505043321806 10.2337/diacare.21.9.1414 10.1136/bjo.2005.082271 10.1016/S0161-6420(03)00564-5 |
ContentType | Journal Article |
Copyright | Jingi et al.; licensee BioMed Central. 2015. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated. COPYRIGHT 2015 BioMed Central Ltd. Copyright Tehran University of Medical Sciences Publications Apr 2015 Jingi et al.; licensee BioMed Central. 2015 |
Copyright_xml | – notice: Jingi et al.; licensee BioMed Central. 2015. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated. – notice: COPYRIGHT 2015 BioMed Central Ltd. – notice: Copyright Tehran University of Medical Sciences Publications Apr 2015 – notice: Jingi et al.; licensee BioMed Central. 2015 |
DBID | C6C NPM AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU CWDGH FYUFA GHDGH K9. M0S PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1186/s40200-015-0151-4 |
DatabaseName | Springer Nature OA Free Journals PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central ProQuest Central ProQuest One Community College Middle East & Africa Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection Middle East & Africa Database ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2251-6581 |
EndPage | 21 |
ExternalDocumentID | 3690967041 A541669124 10_1186_s40200_015_0151_4 25866740 |
Genre | Journal Article General Information |
GroupedDBID | -A0 -EM 2NT 3V. 406 5VS 7X7 8FI 8FJ AAFGU AAHNG AATNV AAUYE AAYFA ABDZT ABECU ABFGW ABFTV ABKAS ABKCH ABMQK ABSXP ABTEG ABTKH ABTMW ABUWG ACBMV ACBRV ACBYP ACGFS ACHSB ACIGE ACIPQ ACOKC ACTTH ACVWB ACWMK ADBBV ADINQ ADKNI ADMDM ADOXG ADRAZ ADURQ ADYFF AEFTE AESKC AESTI AEVTX AFGXO AFKRA AFNRJ AFQWF AGDGC AGGBP AGJBK AGMZJ AHBYD AHSBF AHYZX AIAKS AILAN AIMYW AITGF AJDOV AJZVZ AKQUC ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AOIJS AXYYD BENPR BFQNJ BPHCQ BVXVI C24 C6C CCPQU CWDGH DPUIP EBLON EBS EJD FINBP FNLPD FSGXE FYUFA GGCAI GROUPED_DOAJ HMCUK HYE IAO IHR IHW IKXTQ ITC IWAJR J-C JZLTJ KQ8 LLZTM M48 M~E NPVJJ NQJWS O9J OK1 PQQKQ PROAC PT4 RBZ ROL RPM RSV SMD SNE SNPRN SOHCF SOJ SRMVM SSLCW STPWE UKHRP UOJIU UTJUX Z7W ZMTXR 0R~ AACDK AAJBT AASML ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU ALIPV BAWUL DIK FIGPU GX1 H13 IPNFZ NPM RIG SJYHP AAYXX CITATION 7XB 8FK K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c568t-ea951b55f4324e2651fcb05d094d616f88fbfb1582e9ccb87c489b80a71b1be23 |
IEDL.DBID | RPM |
ISSN | 2251-6581 |
IngestDate | Tue Sep 17 21:25:16 EDT 2024 Fri Aug 16 05:30:03 EDT 2024 Fri Sep 20 00:52:16 EDT 2024 Wed Aug 14 18:51:31 EDT 2024 Tue Aug 13 05:22:15 EDT 2024 Tue Aug 20 22:14:19 EDT 2024 Thu Sep 12 18:48:31 EDT 2024 Sat Sep 28 08:49:20 EDT 2024 Sat Dec 16 12:04:56 EST 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Glaucoma Diabetic retinopathy Cataract Cameroon Visual impairment Diabetes Diabetic maculopathy Sub-Saharan Africa |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c568t-ea951b55f4324e2651fcb05d094d616f88fbfb1582e9ccb87c489b80a71b1be23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392737/ |
PMID | 25866740 |
PQID | 1682251140 |
PQPubID | 105772 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4392737 proquest_miscellaneous_1673074601 proquest_journals_1682251140 gale_infotracmisc_A541669124 gale_infotracacademiconefile_A541669124 gale_healthsolutions_A541669124 crossref_primary_10_1186_s40200_015_0151_4 pubmed_primary_25866740 springer_journals_10_1186_s40200_015_0151_4 |
PublicationCentury | 2000 |
PublicationDate | 4-8-2015 |
PublicationDateYYYYMMDD | 2015-04-08 |
PublicationDate_xml | – month: 04 year: 2015 text: 4-8-2015 day: 08 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: Switzerland |
PublicationTitle | Journal of diabetes and metabolic disorders |
PublicationTitleAbbrev | J Diabetes Metab Disord |
PublicationTitleAlternate | J Diabetes Metab Disord |
PublicationYear | 2015 |
Publisher | BioMed Central BioMed Central Ltd |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd |
References | Wild, Rophic, Green, Sicree, King (CR10) 2004; 27 Rotimi, Daniel, Zhou, Obisesan, Chen, Chen (CR3) 2003; 13 Oye, Kuper, Dineen, Befidi-Mengue, Foster (CR5) 2006; 90 Roaeid, Kadiki (CR15) 2011; 3 Bourne, Sukudom, Foster, Tantisevi, Jitapunkul, Lee (CR8) 2003; 87 Bella–Hiag, Ebana Mvogo, Ngosso, Ellong (CR9) 1996; 19 Fanatsu, Suto, Horis, Kitamura, Iwakiri, Iwasaki (CR4) 1993; 97 CR13 Kahloun, Jelliti, Zouali, Attia, Ben Yahia, Resnikoff (CR16) 2014; 28 Merle, Renard, Donnio, Richer, Ayeboua, Ensfelder (CR6) 2004; 27 Resnikoff, Pascolini, Etya’ale, Kocur, Pararajaseqaram, Pokharel (CR1) 2004; 82 Jingi, Noubiap, Ellong, Bigna, Mvogo (CR12) 2014; 14 Katte, Dzucie, Sobngwi, Mbong, Fetse, Kouam (CR18) 2014; 14 Langman, Lancashire, Cheng, Steward (CR20) 2005; 89 Raman, Pal, Adams, Rani, Vaitheeswaran, Sharma (CR19) 2010; 51 Tielsch, Javitt, Coleman, Katz, Sommer (CR2) 1995; 332 Narendran, John, Raghuran, Ravindran, Nirmalan, THulasiraj (CR14) 2002; 86 Romakrishnan, Nirmalan, Krishnadas, Thulasiraj, Tielsch, Katz (CR7) 2003; 110 Leske, Wu, Hennis, Connell, Hyman, Schachat (CR21) 1999; 106 King, Aubert, Herman (CR11) 1998; 21 (CR17) 2004; 53 13677425 - Ethn Dis. 2003 Summer;13(2 Suppl 2):S110-7 15029040 - J Fr Ophtalmol. 2004 Feb;27(2):136-42 9917778 - Ophthalmology. 1999 Jan;106(1):35-41 24564334 - BMC Ophthalmol. 2014 Feb 24;14:19 16622082 - Br J Ophthalmol. 2006 May;90(5):538-42 12917161 - Ophthalmology. 2003 Aug;110(8):1484-90 12185129 - Br J Ophthalmol. 2002 Sep;86(9):1014-8 9727886 - Diabetes Care. 1998 Sep;21(9):1414-31 15640920 - Bull World Health Organ. 2004 Nov;82(11):844-51 15111519 - Diabetes Care. 2004 May;27(5):1047-53 25000848 - BMC Public Health. 2014 Jul 08;14:696 24924439 - Eye (Lond). 2014 Aug;28(8):986-91 15549022 - MMWR Morb Mortal Wkly Rep. 2004 Nov 19;53(45):1069-71 20610838 - Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6253-61 8368183 - Nippon Ganka Gakkai Zasshi. 1993 Aug;97(8):947-54 16024843 - Br J Ophthalmol. 2005 Aug;89(8):960-3 12928267 - Br J Ophthalmol. 2003 Sep;87(9):1069-74 7700315 - N Engl J Med. 1995 May 4;332(18):1205-9 8959098 - J Fr Ophtalmol. 1996;19(10):585-90 AL Bella–Hiag (151_CR9) 1996; 19 R Raman (151_CR19) 2010; 51 Centers for Disease Control and Prevention (CDC) (151_CR17) 2004; 53 H Fanatsu (151_CR4) 1993; 97 MJ Langman (151_CR20) 2005; 89 JC Katte (151_CR18) 2014; 14 MC Leske (151_CR21) 1999; 106 S Resnikoff (151_CR1) 2004; 82 S Wild (151_CR10) 2004; 27 JE Oye (151_CR5) 2006; 90 RR Bourne (151_CR8) 2003; 87 H Merle (151_CR6) 2004; 27 H King (151_CR11) 1998; 21 151_CR13 R Kahloun (151_CR16) 2014; 28 RB Roaeid (151_CR15) 2011; 3 R Romakrishnan (151_CR7) 2003; 110 JM Tielsch (151_CR2) 1995; 332 V Narendran (151_CR14) 2002; 86 C Rotimi (151_CR3) 2003; 13 AM Jingi (151_CR12) 2014; 14 |
References_xml | – volume: 106 start-page: 35 issue: 1 year: 1999 end-page: 41 ident: CR21 article-title: Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados eye study publication-title: Ophthalmology doi: 10.1016/S0161-6420(99)90003-9 contributor: fullname: Schachat – volume: 87 start-page: 1069 issue: 9 year: 2003 end-page: 1074 ident: CR8 article-title: Prevalence of glaucoma in Thailand: a population based survey in Rom Klao District, Bangkok publication-title: Br J Ophthalmol doi: 10.1136/bjo.87.9.1069 contributor: fullname: Lee – volume: 51 start-page: 6253 issue: 12 year: 2010 end-page: 61 ident: CR19 article-title: Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetics Study, report no. 17 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.10-5414 contributor: fullname: Sharma – volume: 97 start-page: 947 issue: 8 year: 1993 end-page: 954 ident: CR4 article-title: Prevalence of diabetic ocular complications and systemic factors publication-title: Nippon Ganka Gakkai Zasshi contributor: fullname: Iwasaki – volume: 13 start-page: S110 issue: Suppl 2 year: 2003 end-page: S117 ident: CR3 article-title: Prevalence and determinants of diabetic retinopathy and cataracts in West African Type 2 diabetes patients publication-title: Ethn Dis contributor: fullname: Chen – volume: 19 start-page: 585 issue: 10 year: 1996 end-page: 590 ident: CR9 article-title: Intraocular pressure in a young Cameroonian population publication-title: J Fr Ophtalmol contributor: fullname: Ellong – volume: 82 start-page: 844 year: 2004 end-page: 851 ident: CR1 article-title: Global data on visual impairment in the year 2002 publication-title: Bull World Health Organ contributor: fullname: Pokharel – volume: 14 start-page: 19 year: 2014 ident: CR12 article-title: Epidemiology and treatment outcomes of diabetic retinopathy in a diabetic population from Cameroon publication-title: BMC Ophthalmol doi: 10.1186/1471-2415-14-19 contributor: fullname: Mvogo – ident: CR13 – volume: 14 start-page: 696 issue: 1 year: 2014 ident: CR18 article-title: Coincidence of diabetes and hypertension in a semi-urban Cameroonian population: a cross-sectional study publication-title: BMC Public Health doi: 10.1186/1471-2458-14-696 contributor: fullname: Kouam – volume: 27 start-page: 1047 issue: 5 year: 2004 end-page: 1053 ident: CR10 article-title: Global prevalence of diabetes: estimates for the year 2030 publication-title: Diabetes Care doi: 10.2337/diacare.27.5.1047 contributor: fullname: King – volume: 86 start-page: 1014 year: 2002 end-page: 1018 ident: CR14 article-title: Diabetic retinopathy among self-reported diabetics in Southern India: a population based assessment publication-title: Br J Ophthalmol doi: 10.1136/bjo.86.9.1014 contributor: fullname: THulasiraj – volume: 27 start-page: 136 issue: 2 year: 2004 end-page: 142 ident: CR6 article-title: Glaucoma screening in Martinique. Results in 813 hospital employees publication-title: J Fr Ophthalmol doi: 10.1016/S0181-5512(04)96107-4 contributor: fullname: Ensfelder – volume: 3 start-page: 5 year: 2011 ident: CR15 article-title: Prevalence of long-term complications among Type 2 diabetic patients in Benghazi, Libya publication-title: J Diabetol contributor: fullname: Kadiki – volume: 28 start-page: 986 issue: 8 year: 2014 end-page: 91 ident: CR16 article-title: Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa publication-title: Eye (Lond) doi: 10.1038/eye.2014.131 contributor: fullname: Resnikoff – volume: 89 start-page: 960 issue: 8 year: 2005 end-page: 963 ident: CR20 article-title: Systemic hypertension and glaucoma: mechanisms in common and co-occurrence publication-title: Br J Ophthalmol doi: 10.1136/bjo.2004.053397 contributor: fullname: Steward – volume: 332 start-page: 1205 issue: 18 year: 1995 end-page: 1209 ident: CR2 article-title: The prevalence of blindness and visual impairment among nursing home residence in Baltimore publication-title: N Engl J Med doi: 10.1056/NEJM199505043321806 contributor: fullname: Sommer – volume: 21 start-page: 1414 issue: 9 year: 1998 end-page: 1431 ident: CR11 article-title: Global burden of diabetes. 1995–2025. Prevalence, numerical estimates and projections publication-title: Diabetes Care doi: 10.2337/diacare.21.9.1414 contributor: fullname: Herman – volume: 90 start-page: 538 issue: 5 year: 2006 end-page: 542 ident: CR5 article-title: Prevalence and causes of blindness and visual impairment in Muyuka: a rural health district in the South West Province, Cameroon publication-title: Br J Ophthalmol doi: 10.1136/bjo.2005.082271 contributor: fullname: Foster – volume: 53 start-page: 1069 issue: 45 year: 2004 end-page: 1071 ident: CR17 article-title: Prevalence of visual impairment and selected eye diseases among patients aged ≥50 years with and without diabetes-United States, 2002 publication-title: MMWR Morb Mortal Wkly Rep – volume: 110 start-page: 1484 issue: 8 year: 2003 end-page: 1490 ident: CR7 article-title: Glaucoma in a rural population of Southern India: the Aravind comprehensive eye survey publication-title: Ophtalmology doi: 10.1016/S0161-6420(03)00564-5 contributor: fullname: Katz – volume: 28 start-page: 986 issue: 8 year: 2014 ident: 151_CR16 publication-title: Eye (Lond) doi: 10.1038/eye.2014.131 contributor: fullname: R Kahloun – volume: 27 start-page: 1047 issue: 5 year: 2004 ident: 151_CR10 publication-title: Diabetes Care doi: 10.2337/diacare.27.5.1047 contributor: fullname: S Wild – volume: 82 start-page: 844 year: 2004 ident: 151_CR1 publication-title: Bull World Health Organ contributor: fullname: S Resnikoff – volume: 86 start-page: 1014 year: 2002 ident: 151_CR14 publication-title: Br J Ophthalmol doi: 10.1136/bjo.86.9.1014 contributor: fullname: V Narendran – volume: 14 start-page: 696 issue: 1 year: 2014 ident: 151_CR18 publication-title: BMC Public Health doi: 10.1186/1471-2458-14-696 contributor: fullname: JC Katte – volume: 90 start-page: 538 issue: 5 year: 2006 ident: 151_CR5 publication-title: Br J Ophthalmol doi: 10.1136/bjo.2005.082271 contributor: fullname: JE Oye – volume: 110 start-page: 1484 issue: 8 year: 2003 ident: 151_CR7 publication-title: Ophtalmology doi: 10.1016/S0161-6420(03)00564-5 contributor: fullname: R Romakrishnan – volume: 53 start-page: 1069 issue: 45 year: 2004 ident: 151_CR17 publication-title: MMWR Morb Mortal Wkly Rep contributor: fullname: Centers for Disease Control and Prevention (CDC) – volume: 87 start-page: 1069 issue: 9 year: 2003 ident: 151_CR8 publication-title: Br J Ophthalmol doi: 10.1136/bjo.87.9.1069 contributor: fullname: RR Bourne – ident: 151_CR13 – volume: 89 start-page: 960 issue: 8 year: 2005 ident: 151_CR20 publication-title: Br J Ophthalmol doi: 10.1136/bjo.2004.053397 contributor: fullname: MJ Langman – volume: 3 start-page: 5 year: 2011 ident: 151_CR15 publication-title: J Diabetol contributor: fullname: RB Roaeid – volume: 19 start-page: 585 issue: 10 year: 1996 ident: 151_CR9 publication-title: J Fr Ophtalmol contributor: fullname: AL Bella–Hiag – volume: 13 start-page: S110 issue: Suppl 2 year: 2003 ident: 151_CR3 publication-title: Ethn Dis contributor: fullname: C Rotimi – volume: 27 start-page: 136 issue: 2 year: 2004 ident: 151_CR6 publication-title: J Fr Ophthalmol doi: 10.1016/S0181-5512(04)96107-4 contributor: fullname: H Merle – volume: 97 start-page: 947 issue: 8 year: 1993 ident: 151_CR4 publication-title: Nippon Ganka Gakkai Zasshi contributor: fullname: H Fanatsu – volume: 14 start-page: 19 year: 2014 ident: 151_CR12 publication-title: BMC Ophthalmol doi: 10.1186/1471-2415-14-19 contributor: fullname: AM Jingi – volume: 51 start-page: 6253 issue: 12 year: 2010 ident: 151_CR19 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.10-5414 contributor: fullname: R Raman – volume: 21 start-page: 1414 issue: 9 year: 1998 ident: 151_CR11 publication-title: Diabetes Care doi: 10.2337/diacare.21.9.1414 contributor: fullname: H King – volume: 332 start-page: 1205 issue: 18 year: 1995 ident: 151_CR2 publication-title: N Engl J Med doi: 10.1056/NEJM199505043321806 contributor: fullname: JM Tielsch – volume: 106 start-page: 35 issue: 1 year: 1999 ident: 151_CR21 publication-title: Ophthalmology doi: 10.1016/S0161-6420(99)90003-9 contributor: fullname: MC Leske |
SSID | ssj0000778816 |
Score | 2.099087 |
Snippet | Background
“Vision 2020 – the right to sight” is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of... "Vision 2020 - the right to sight" is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of concrete... Background "Vision 2020 - the right to sight" is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of... BACKGROUND"Vision 2020 - the right to sight" is a program which purpose is to eliminate avoidable blindness by the year 2020 through the implementation of... |
SourceID | pubmedcentral proquest gale crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 21 |
SubjectTerms | Blindness Cataract Complications and side effects Diabetes Diabetic retinopathy Diabetics Endocrinology Glaucoma Hypertension Medicine Medicine & Public Health Metabolic Diseases Ophthalmology Research Article Risk factors |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LatwwcEgTKL2Uvus8WhUKhRazlmw93EtIQ8JSmlDaBnIzli2RPdSbxrv5_szYshsvtAefNDLSaEYzo3kBvDdKe1-JNBayRgMFJV6c59LFwguZlsIKZSk5-exczS-yr5fycgvmQy4MhVUOd2J3UdfLit7IZ1yhKEPtIEtmpaVXgGo1O7z-E1P_KPKzhmYaD2BH8IwctjtfTs6__xjfWxJNhdNVcGxyo2YtmU4UlUXRaxIXOhFNmxf0PQm1GT254ULtJNPpE3gcVEp21NPAU9hyzTN4eBac5s_hW4h6aVnZ1Ox20a4RmrIjFzf0NMgWDWvXNv5ZUu3mhvWdgz4zF_qNMspAYcflb4dKdvMCLk5Pfh3P49BEIa6kMqvYlahDWSk9ld5zQknuK5vIGs26WnHljfHWWy6NcHlVWaOrzOTWJKXmllsn0pew3Swb9xoY56l2qdGpcnmmtbdJ7U2tvaM_WVVG8HHAX3Hd18ooOhvDqKJHdoGIpo8XWQRvCcNFn-458llxJPH0VI5qRwQfOgjiNDrvMiQM4GKoZtUEcn8CiRxSTYeHUywCh7bFX3qK4N04TDMp6qxxyzXB4P2nM7RZI3jVH_q4MSGNUppm6wk5jABUt3s60iyuuvrdyBGoNOoIPg2Ec29Z_8LX7v83sQePREfJWZyYfdhe3azdAapLK_smcMIdZz4R1A priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEB_OE8SXw2-rp0YQBKVem-argshxeBzi-qIL91aaNsEFzZ3bXdH_3pk2XbbL-eJDnzJp2slM8ptkPgBeGKW9b3iRctmigYI7XlqW0qXcc1nU3HJlKTh59lmdzcXHc3m-B2N5q8jA7krTjupJzZff3_z--ec9Kvy7XuGNOurIBiL3KnJDkzjiNbjORSFI4GcR7fcLs6bc6SrebV7Zk3IDS6OUpsOQrY1qd7ne2q92fSl3LlT7fer0FhxEgMmOB4m4DXsu3IEbs3iFfhc-RR-YjtWhZb8W3RqpKVZysaSDQrYIrFvb9EtNmZwDG-oIvWUuVh9lFI_CTuofDiF3uAfz0w9fT87SWFIhbaQyq9TViKislJ4S8TmuZO4bm8kWjbxW5cob4623uTTclU1jjW6EKa3Jap3b3Dpe3If9cBHcQ2B5XmhXGF0oVwqtvc1ab1rtHb3JqjqBVyP_qsshc0bVWxxGVQPfK-Q5PXklEnhGHK6G4M-N1lXHEgGjKhGEJPCypyBJQEY3dQwfwI-hDFYTysMJJepLM20eZ7Eaxa3KFQIlxJ4iS-D5ppl6kg9acBdrosHVUAu0YBN4MEz65sdGoUlAT8RhQ0BZvKctYfGtz-aN-oEQUifwehScrc_6F78e_fc4j-Em7-VdpJk5hP3Vcu2eIK5a2ae9tvwFBfwdEw priority: 102 providerName: Scholars Portal – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BkSouiEehgQJGQkJqFTV24ke4VSuqClEuUKk3K05ssYe6qNnl9zOTeKPNqhw45OSx5Yxn7G88DwN8NEqH0IoyF7JDAwVPvLyupc9FELJshBPKUXLy5Xd1cVV9vZbXqVg05cJs---5Uac92TcUOkUhZhJHewiPJKIU0sGFWkzXKYWmuugq-S3v7Tk7eXb3360DaDc4csdDOhw850_hSUKM7Gxc4mfwwMfnsH-ZfOIv4FsKaulZEzv2Z9mvkZqSH5d3dPPHlpH1a5f_aKg0c2Tjw0CfmU_PiTJKMGGL5sYjho4HcHX-5efiIk9vJOStVGaV-wYhkpMyUGU9L5TkoXWF7NBq6xRXwZjgguPSCF-3rTO6rUztTNFo7rjzonwJe_E2-kNgnJfal0aXyteV1sEVXTCdDp5GcqrJ4HjDP_t7LIVhBxPCKDsy2yKj6eO2yuA9cdiO2ZyTGtkziQhQ1YgqMvg0UJAiIaPbJuUD4GSoJNWM8mhGiQrQzps3q2iTAvaWK0Q-CCarIoMPUzP1pKCy6G_XRIPbm67QJM3g1bjo048JaZTS1FvPxGEioLLc85a4_DWU50aBR0yoMzjZCM7WtP7Fr9f_Rf0GHotBsKu8MEewt7pb-7cIjlbu3aAWfwHLjAUY priority: 102 providerName: Springer Nature |
Title | Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon |
URI | https://link.springer.com/article/10.1186/s40200-015-0151-4 https://www.ncbi.nlm.nih.gov/pubmed/25866740 https://www.proquest.com/docview/1682251140/abstract/ https://search.proquest.com/docview/1673074601 https://pubmed.ncbi.nlm.nih.gov/PMC4392737 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1da9tATLQdjL2Mfc9bl3kwGGy4sc--D-8tMQ1lLKFsK-TN-Ow7aliupU76-yv5IySBvezBNvjksyxLJ-lO0gF8VkJaW7I4YLxCBwU1XpCm3ATMMh4XTDOhKTl5vhAXV8mPJV8eAR9yYdqg_VLXZ-7v6szV121s5e2qHA9xYuPLeYZdotaV42M4lnG846K3w6-kCumiX8GMlBg35CNR-BWFqXHEiCoAcyWEpCmPHXV0OCjvaKXDiMmDZdNWG82ewdPejPQnHbrP4ci4F_B43i-Uv4SffaRL4xeu8u_rZoPQlBFZ39F0oF87v9no4HdB9Zqd3-0W9N03_R6jPmWd-FmxMmhYu1dwNTv_k10E_cYJQcmFWgemQLtJc26p3J5hgke21CGv0JWrRCSsUlZbHXHFTFqWWskyUalWYSEjHWnD4tdw4m6ceQt-FMXSxErGwqSJlFaHlVWVtIZ60qLw4OtAv_y2q4-Rt36FEnlH9xxpTkeUJx58JArnXYrnVrbyCUezUKRoanjwpYUg6UJCl0WfJIDIUJ2qPcjTPUiUinK_efiLeS-VTR4JNIfQwkxCDz5tm-lJijRz5mZDMDjmyQT9VA_edD99-2ED03gg99hhC0C1uvdbkIXbmt09y3rwbWCcHbT-Ra93__2e9_CEtfyeBKE6hZP13cZ8QOtprUcoM0s5gkeT2XS6wOv0fHH5C-9mIsPzPFGjVp4eAGs1G4U |
link.rule.ids | 230,315,733,786,790,891,12083,21416,24346,27957,27958,31754,31755,33779,33780,41155,42224,43345,43840,51611,53827,53829,74102,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LbtQwcARFAi6IN4FCjYSEBIoaO_EjXFBVUS2w2wuttDcrTmx1D2TbZrffz0ziXZqV4JCTx5E9nqc9D4APRukQapGnQjbooKDGS8tS-lQEIfNKOKEcJSfPTtXkvPgxl_N44dbFsMqNTOwFdbOs6Y78kCtUZWgdFNnXy6uUukbR62psoXEX7hV5XlBIn57r7R1LpqlYuoqPmdyow47cJYrEoog1iYsbqaNdoXxLK-1GTO48m_ba6OQxPIpmJDsazv0J3PHtU7g_iw_lz2AaI106VrUNu1l0a4SmjMjFNV0HskXLurVLf1VUr7llQ7egL8zHHqOMsk7YcfXbo2HdPofzk29nx5M0Nk5Ia6nMKvUV2k1OykDl9rxQkofaZbJBV65RXAVjgguOSyN8WdfO6LowpTNZpbnjzov8Bey1y9a_AsZ5rn1udK58WWgdXNYE0-jg6U9OVQl82uDPXg71MWzvVxhlB2RbRDR93BYJHBCG7ZDiueUteyTRLFQlmhoJfOwhiLsQ0XUVkwRwMVSnagS5P4JErqjHw5tTtJErO_uXhhJ4vx2mmRRp1vrlmmBQ5ukC_dQEXg6Hvt2YkEYpTbP1iBy2AFSrezzSLi76mt3IBWgo6gQ-bwjn1rL-ha_X_9_EATyYnM2mdvr99OcbeCh6qi7SzOzD3up67d-iubRy73qe-AOrUQ-h |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LbtQw0IJWqrgg3g0t1EhISKBoYyd-hAsqpasC7aoCKvVmxYkt9oC3bXb5fmYSb2hWgkNOHkf2eF72vAh5raXyvuZ5ykUDFxTQeGlZCpdyz0VecculxeTks5k8uSi-XIrLGP_UxrDKtUzsBHWzqPGNfMIkqDKwDops4mNYxPmn6Yer6xQ7SKGnNbbTuEu2VSEFUPj2x-PZ-bfhxSVTWDpdRtcm03LS4uUJ47Iwfk3AUkfKaVNE39JRm_GTG07UTjdNH5D70aikhz0VPCR3XHhEds6i2_wxOY1xLy2tQkN_z9sVQGN-5PwGHwfpPNB2ZdPvFVZvDrTvHfSeuthxlGIOCj2qfjkws8MTcjE9_nF0ksY2CmktpF6mrgIrygrhsfie41IwX9tMNHCxaySTXmtvvWVCc1fWtdWqLnRpdVYpZpl1PH9KtsIiuF1CGcuVy7XKpSsLpbzNGq8b5R3-ycoqIW_X-DNXfbUM090ytDQ9sg0gGj9mioQcIIZNn_A5cJo5FGAkyhIMj4S86SCQ1wDRdRVTBmAxWLVqBLk_ggQeqcfD61M0kUdb85eiEvJqGMaZGHcW3GKFMCABgZwylpBn_aEPG-NCS6lwthqRwwCAlbvHI2H-s6vgDTwBZqNKyLs14dxa1r_w9fz_mzggO8AQ5vTz7Oseucc7oi7STO-TreXNyr0A22lpX0am-ANYJRVE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diabetes+and+visual+impairment+in+sub-Saharan+Africa%3A+evidence+from+Cameroon&rft.jtitle=Journal+of+diabetes+and+metabolic+disorders&rft.au=Jingi%2C+Ahmadou+M&rft.au=Nansseu%2C+Jobert+Richie+N&rft.au=Noubiap%2C+Jean+Jacques+N&rft.au=Bilong%2C+Yannick&rft.date=2015-04-08&rft.pub=BioMed+Central&rft.eissn=2251-6581&rft.volume=14&rft_id=info:doi/10.1186%2Fs40200-015-0151-4&rft_id=info%3Apmid%2F25866740&rft.externalDBID=PMC4392737 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2251-6581&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2251-6581&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2251-6581&client=summon |